Table 3. Synthetic oligonucleotides for amplification of the CSBV genome.

Primers	Sequence (5′ to 3′)	Nucleotide position
S1 F	GAAATAAGAATACGAATCGT	1–20
S1 R	TAAACAAATCGGTATAAGAGTCC	379–401
S2 F	GACCCGTTTTCTTGTGAGTTTTAG	41–64
S2 R	GTGTAGCGTCCCCCTGAATAGAT	611–633
S3 F	CGTAATTGCGGAGTGGAAAGAT	273–294
S3 R	CCCCTAAATTGTTGCGTTGGTT	739–760
S4 F	TATTCAGGGGGACGCTACAC	614–633
S4 R	TATTCCATCGGGGTTATTTG	1,713–1,732
S5 F	GGAGACGCGCATGGTAAAGA	1,644–1,663
S5 R	GCGCGGTAAATAAACACTCG	2,365–2,384
S6 F	ATGGGGGTAAGGGACAATCTG	2,290–2,310
S6 R	TGCTCTAACCTCGCATCAAC	3,423–3,442
S7 F	TTACGGGAGCAGCACAACA	3,391–3,409
S7 R	ATTTCCGATTTACCGATACC	4,287–4,306
S8 F	CGGTGCGTTATGAACCTTTT	4,243–4,262
S8 R	AATGCGTAGATTGAGGTGCC	5,333–5,352
S9 F	TACTATCCGCCCCCTAAGC	3,195–3,213
S9 R	GTGCCCCATCGTTCAAAA	5,432–5,449
S10 F	GCGCAACTGGCACCTCAAT	5,325–5,343
S10 R	TTCCAAATATACTTCCCACTGC	6,249–6,270
S11 F	GCTGGGCCTTCTTATCTGGTG	3,873–3,893
S11 R	TACGGGTCCTCTGCAATGTTCT	6,363–6,384
S12 F	GTGACGGCAGTGGGAAGTAT	6,262–6,243
S12 R	GCAGCCTCCTCAGGTGTTAGT	7,454–7,474
S13 F	TTTGGTAGCGGGGTGTAAG	7,322–7,340
S13 R	CATTGCGTGGTATCATT	8,501–8,517